arsenic has been researched along with Black Fever in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| TELLA, A | 1 |
| Ahmed, G; Chaturvedi, SK; Jamal, F; Kumar, A; Narayan, S; Pandey, K; Rai, SN; Singh, SK; Singh, V; Tiwari, RK; Vamanu, E | 1 |
| Ahmed, G; Bimal, S; Chaturvedi, SK; Choudhary, SK; Das, P; Jamal, F; Narayan, S; Shivam, P; Singh, MK; Singh, SK; Thakur, AK | 1 |
| Fairlamb, AH; Feldmann, J; Perry, MR; Raab, A; Wyllie, S | 1 |
| McConville, MJ; Ralph, SA | 1 |
| Boelaert, M; Chakraborti, D; Fairlamb, AH; Feldmann, J; Menten, J; Perry, MR; Picado, A; Prajapati, VK; Raab, A; Sundar, S | 1 |
| Das, P; Das, S; Ghosh, AK; Kesari, S; Kumar, A; Lal, CS; Mandal, R; Pandey, K; Purkait, B; Rabidas, VN; Verma, N | 1 |
| Boelaert, M; Fairlamb, AH; Feldmann, J; Perry, MR; Prajapati, VK; Sundar, S; Wyllie, S | 1 |
8 other study(ies) available for arsenic and Black Fever
| Article | Year |
|---|---|
CHEMOTHERAPY OF TROPICAL DISEASES.
Topics: Amebiasis; Amebicides; Anti-Bacterial Agents; Antimalarials; Antimony; Arsenicals; Chagas Disease; Chloroquine; Dysentery, Amebic; Emetine; Humans; Iodoquinol; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Malaria; Suramin; Trypanosomiasis; Trypanosomiasis, African; United States | 1964 |
Arsenic exposure to mouse visceral leishmaniasis model through their drinking water linked to the disease exacerbation via modulation in host protective immunity: a preclinical study.
Topics: Animals; Arsenic; Disease Progression; Drinking Water; Humans; Leishmania donovani; Leishmaniasis, Visceral; Mice | 2023 |
Modulation of the immune response and infection pattern to Leishmania donovani in visceral leishmaniasis due to arsenic exposure: An in vitro study.
Topics: Animals; Arsenic; Cytokines; Leishmania donovani; Leishmaniasis, Visceral; Macrophages, Peritoneal; Mice; Nitric Oxide; Reactive Oxygen Species | 2019 |
Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenic; Cell Line; Drinking Water; Drug Resistance; Environmental Exposure; India; Leishmania; Leishmaniasis, Visceral; Macrophages; Mass Screening; Mass Spectrometry; Mice; Mice, Inbred BALB C; Water Pollutants, Chemical | 2013 |
Chronic arsenic exposure and microbial drug resistance.
Topics: Animals; Antiprotozoal Agents; Arsenic; Drinking Water; Drug Resistance; Environmental Exposure; Leishmania; Leishmaniasis, Visceral; Water Pollutants, Chemical | 2013 |
Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study.
Topics: Adolescent; Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenic; Child; Child, Preschool; Cohort Studies; Drug Resistance; Female; Humans; India; Leishmaniasis, Visceral; Logistic Models; Male; Middle Aged; Retrospective Studies; Treatment Failure | 2015 |
Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenic; Child; Child, Preschool; Cohort Studies; Drinking Water; Environmental Exposure; Environmental Pollutants; Female; Humans; India; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Logistic Models; Male; Middle Aged; Odds Ratio; Retrospective Studies; Time Factors; Young Adult | 2016 |
Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?
Topics: Antimony; Antiprotozoal Agents; Arsenic; Drug Resistance; Humans; India; Leishmania; Leishmania donovani; Leishmania infantum; Leishmaniasis, Visceral; Poisons; Treatment Failure | 2011 |